Quest Diagnostics (DGX) Operating Expenses (2009 - 2026)

Quest Diagnostics has disclosed Operating Expenses across 18 years of filings, most recently posting $2.6 billion for Q2 2026.

• In Q2 2026, Operating Expenses rose 11.24% year-over-year to $2.6 billion; the TTM figure through Jun 2026 stood at $9.9 billion (up 9.76% YoY), while the FY2025 annual figure was $9.5 billion, up 11.18% from the prior year.
• Operating Expenses came in at $2.6 billion for Q2 2026 at Quest Diagnostics, up from $2.5 billion in the prior quarter.
• In the past five years, Operating Expenses ranged from a high of $2.6 billion in Q2 2026 to a low of $2.0 billion in Q3 2023.
• Average Operating Expenses over 5 years is $2.2 billion, with a median of $2.1 billion recorded in 2022.
• Year-over-year, Operating Expenses decreased 8.05% in 2023 and grew 13.76% in 2025.
• Over 5 years, Operating Expenses stood at $2.2 billion in 2022, then dropped by 8.05% to $2.0 billion in 2023, then gained by 11.83% to $2.3 billion in 2024, then grew by 7.08% to $2.4 billion in 2025, then increased by 6.78% to $2.6 billion in 2026.
• Per Business Quant data, the three most recent Operating Expenses figures were $2.6 billion in Q2 2026, $2.5 billion in Q1 2026, and $2.4 billion in Q4 2025.